does tirzepatide cause allodynia GLP-1 Drugs: New Reports of Dysesthesia and How Tirzepatide Support Medical Weight

Pressure to Stay on the Drug Indefinitely Weight typically returns once the medication is stopped

Many prescribers say yes

In this Phase 3b, open-label, randomized controlled clinical trial, 751 adult participants with obesity but without type 2 diabetes (BMI 30 or BMI 27 with at least one obesity-related comorbidity, such as hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease) were randomly assigned in a 1:1 ratio to receive once-weekly subcutaneous injections of the maximum tolerated dose of Tirzepatide (10 mg or 15 mg) or Semaglutide (1.7 mg or 2.4 mg) for 72 weeks

reported that GSH over-accumulation in S